User Name Password

back to homepage

London Capital (LCG.L) - trading update: ahead of expectations – again
LCG.L
Comment by Andy Hartwill , Jul 02, 2008
Click for previous reports on this company
Questions? Contact our analyst

London Capital Group Holdings (LCG) today published a trading update covering the first half that ended on 30 June 2008. The group expects pre-tax profit to be “significantly ahead of original management expectations and approximately 50% ahead of the same period last year”.

It reports increased volumes and revenues across the group and notes that “current market conditions continue to favour the business model”. The recently acquired FuturesBetting.com, based in Gibraltar, is expected to go live later this month.

The Board has announced its intention to pay an interim dividend of 2.5p, a 100% increase on the interim dividend last year.

Interim results are scheduled to be announced on 7 August 2008.

Objective's view:

The trading statement comes on the same day, and in marked contrast to, that from Marks and Spencer which shocked the market with the extent of doom it has experienced on the High Street. What is particularly telling in the LCG statement, beyond the indications of the strength of the performance, is the reference to the “current market conditions (as continuing) to favour the (LCG) business model”.

The bottom may have dropped out of the M&S underwear market, as a result of the credit crunch, but demand continues to grow for LCG’s spread-betting offering, and from its other services. Capital Spreads is, as expected, growing both organically under its own brand and through white label partnerships more of which are in negotiation. In the year-ended December 2007 it contributed over 70% of net Group revenue (after brokerage and hedging costs).

Trading volumes at Capital Forex “remain robust” which, in the context of LCG, sounds almost conservative.

Pre-tax profit at the interim stage last year was £3.9m. The statement today that management expects pre-tax profit this time to be approximately 50% ahead implies a figure of around £6m. Given limited seasonality, that number would be in-line with our recently published, and increased, forecast of £12.6m for the full year (against £8.6m for 2007). Note that our forecasts assumed no contribution from the FuturesBetting.com in Gibraltar and we will watch its launch later this month and subsequent trading with interest.

Altogether we view the trading statement as supportive of our core and optimistic valuations of 458p and 600p respectively

SIGN UP NOW FOR OBJECTIVE'S STOCK RESEARCH - IT'S FREE!

Objective, Independent, Experienced.
Research you can trust!

Yes! Subscribe me for the latest stock research from Objective.
Email address
My Password
My information:
First Name
Family Name
Title:
Job title:
Job function:
Industry:
I am a:
 
To receive occasional printed reports complete your mailing address:
 
Company Name (if any)
Address
 
 
City
Postcode/Zip
Country

Please Read Objective's Terms of Use.


Balkan Resources (Private) - exploring the Perlati copper deposit in Albania
Oct 09, 2009 | Previous Reports

Scancell Holdings (SCLP.PLUS) - differentiated technology and a focused plan offer ingredients for success
Sep 08, 2009 | Previous Reports

Sofame Technologies (SDW.V) - ambitious, but high risk growth strategy
Aug 24, 2009 | Previous Reports

Soho Resources (SOH.V) - substantial upgrade to total resource
Aug 19, 2009 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

e-Therapeutics (ETX.L) - ‘success-predictive’ drug discovery may be the key to new treatment horizons
Nov 18, 2008 | Previous Reports

Great Western Minerals (GWG.V) - pressing ahead with mine-to-market strategy
Nov 07, 2008 | Previous Reports

LiDCO (LID.L) - half year results show early signs of being on track
Oct 30, 2008 | Previous Reports

OCCASIONAL PAPERS

Albania - revisting old frontiers
October, 2008

The rise of independent research (IR Magazine)
March, 2006

Presentation to 2005 AIM Conference
Sept 26, 2005

The Role of Sponsored Research
June 22, 2005

Objective's Corporate Brochure
July 01, 2004

Objective Capital's Contact Information
Partnership, sales and product inquiries: marketing@objectivecapital.co.uk
Media services and conference requests: PR@objectivecapital.co.uk
Subscription and customer service issues: service@objectivecapital.co.uk
Comments or opinions on our analysis: analysis@objectivecapital.co.uk

11-12 Tokenhouse Yard, London EC2R 7AS, United Kingdom
ph +44-(0)870-080 2965 fax +44-(0)870-116 0839

About Us | Contact Us
Latest Analysis | Register Free | Archives
 
Copyright 2004 Objective Capital. All rights reserved.
Terms of Use | Privacy Policy | Disclaimer